AI Article Synopsis

  • The Italian government implemented strict social distancing and shelter-in-place measures during the COVID-19 pandemic to curb virus transmission.
  • A study surveyed 153 patients with substance use disorders or behavioral addictions to assess the psychological effects of these measures, focusing on symptoms like depression and anxiety.
  • The results indicated moderate levels of psychopathological symptoms, with higher rates observed in residential patients, and suggested a correlation between these symptoms, poor quality of life, and low levels of craving for substances.

Article Abstract

Background: Following the development of the COVID-19 pandemic, a rigid public health strategy of reduced social contact and shelter-in-place has been adopted by the Italian Government to reduce the spread of the virus. In this paper, we aim at evaluating the impact that the COVID-19 pandemic, and the relative containment measures, have had on a real-life sample of patients suffering from substance use disorders (SUDs) and/or behavioral addictions.

Methods: An anonymous questionnaire was filled out by 153 addicted patients, both outpatients and residential inpatients, recruited across Italy and highly representative of the current Italian population suffering from addictions. Psychopathological burden (anxiety and depressive symptomatology, somatization, irritability, and post-traumatic symptoms), quality of life, and craving changes in daily habits were assessed.

Results: In our sample, we found moderate rates of depression (22.9%), anxiety (30.1%), irritability (31.6%), and post-traumatic stress (5.4%) symptoms. Psychopathological burden was globally higher among residential patients. Reported levels of craving were generally low.

Discussion: This study is the first attempt to collect Italian data regarding the effects of the rigid quarantine period, during the COVID-19 pandemic, on patients suffering from a SUD and/or behavioral addictions. The presence of a moderate psychopathological burden correlated to poor quality of life and low craving scores represented the main outcomes. Long-term studies, with follow-up after the end of the restrictive measures, should be considered to implement our findings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497905PMC
http://dx.doi.org/10.3389/fpsyt.2020.572245DOI Listing

Publication Analysis

Top Keywords

psychopathological burden
16
quality life
12
covid-19 pandemic
12
patients suffering
8
and/or behavioral
8
psychopathological
4
burden quality
4
life substance
4
substance users
4
covid-19
4

Similar Publications

Objective: Cognitive and psychiatric symptoms have been increasingly reported after severe acute respiratory syndrome coronavirus 2 infection, developing soon after infection and possibly persisting for several months. We aimed to study this syndrome and start implementing strategies for its assessment.

Methods: Consecutive patients, referred by the infectious disease specialist because of cognitive complaints after COVID-19, were neurologically evaluated.

View Article and Find Full Text PDF

Psychotherapeutic developments in the management of anxiety disorders are evolving, with notable evidence in obsessive compulsive disorder (OCD). Third-wave therapies significantly contribute to the reduction in psychopathological symptoms and, thus, provide a positive turning point in the socio-occupational spectrum of the patient. One such third-wave approach is meta-cognitive therapy (MCT), which addresses cognitive attention syndrome (CAS) and directly prohibits ritualistic behavior, thereby decreasing the burden of symptoms.

View Article and Find Full Text PDF

: Psoriasis is associated with a high psychological burden and comorbidities, such as depression and anxiety. The aim of this study was to evaluate the psychopathological profile of patients with moderate-to-severe plaque psoriasis under systemic treatment and to explore the association between DLQI and alexithymia, depression, and other psychopathological disorders. : In this monocentric, prospective clinical study, 104 adult patients with moderate-to-severe plaque psoriasis were evaluated according to the disease severity (measured by PASI) influence of psoriasis on their quality of life (measured by DLQI) and their psychopathological profile (measured by the BDI, TAS-20, and SCL-90 questionnaires).

View Article and Find Full Text PDF
Article Synopsis
  • Schizophrenia and substance use disorders (SUDs) often occur together, creating clinical challenges like poor mental health, low medication adherence, and high rates of relapse and hospitalization.
  • This narrative review highlights the need for better diagnosis and treatment for patients with these comorbid conditions by examining current evidence and the healthcare system's management practices.
  • Effective treatment should include both pharmacological options, such as partial dopamine agonists, and psychosocial support through an integrated approach that fosters collaboration among healthcare providers and patients.
View Article and Find Full Text PDF
Article Synopsis
  • * An online survey of 1,041 HWs revealed high levels of anxiety (58.1%), depression (27.5%), and trauma-related symptoms (25.9%), along with substantial functional impairment in 67.4% of the participants.
  • * The study suggests that prior mental health issues and being a parent to young children exacerbated the negative impacts on functioning, emphasizing the need for tailored support interventions for HWs during crises.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!